Related Experiment Video
Updated: Feb 13, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Overcoming drug-resistant lung cancer by paclitaxel loaded tetrahedral DNA nanostructures
1State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P. R. China. yunfenglin@scu.edu.cn.
Abstract:
Paclitaxel (PTX) is an effective drug against diseases such as lung cancer, ovarian cancer, and breast cancer. However, multidrug resistance limits the clinical applications of this drug. Tetrahedral DNA nanostructures (TDNs) offer great promise as a drug delivery candidate. In our study, we prepared TDNs that were subsequently loaded with PTX (PTX/TDNs). The cytotoxicity of PTX/TDNs and PTX alone on non-small cell lung cancer (NSCLC) cells (A549) and the PTX-resistant cell line (A549/T) was determined using a cell count kit-8 (CCK-8) assay. PTX/TDNs exerted strong lethality on both cell lines. Moreover, drug resistance was overcome. Furthermore, the mechanisms used by PTX/TDNs to overcome drug resistance were studied. The expression of mdr 1 gene and P-glycoprotein (P-gp) in A549/T was found to be downregulated, thus indicating that TDNs serve as a P-gp inhibitor. We also showed that PTX/TDNs killed cancer cells via apoptosis. Thus, PTX/TDNs have great potential for use as a nanodelivery system for the treatment of PTX-resistant NSCLC.
Insights
Tetrahedral DNA nanostructures loaded with paclitaxel (PTX/TDNs) effectively kill lung cancer cells, including drug-resistant types. This novel nanodelivery system overcomes paclitaxel resistance by inhibiting P-glycoprotein and inducing apoptosis.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Research
Background:
- Paclitaxel (PTX) is a vital chemotherapy drug, but its efficacy is hindered by multidrug resistance (MDR).
- Tetrahedral DNA nanostructures (TDNs) present a promising platform for drug delivery applications.
- Developing effective strategies to overcome PTX resistance is crucial for improving cancer treatment outcomes.
Purpose of the Study:
- To evaluate the efficacy of PTX-loaded TDNs (PTX/TDNs) in overcoming paclitaxel resistance in non-small cell lung cancer (NSCLC).
- To investigate the mechanisms by which PTX/TDNs overcome drug resistance.
- To assess the potential of PTX/TDNs as a nanodelivery system for treating PTX-resistant NSCLC.
Main Methods:
- Preparation and characterization of PTX/TDNs.
- Cytotoxicity assessment of PTX/TDNs and free PTX on NSCLC (A549) and PTX-resistant (A549/T) cell lines using CCK-8 assay.
- Analysis of mdr1 gene and P-glycoprotein (P-gp) expression in A549/T cells.
- Investigation of apoptosis induction by PTX/TDNs.
Main Results:
- PTX/TDNs demonstrated significant cytotoxicity against both sensitive (A549) and resistant (A549/T) NSCLC cells.
- The drug resistance of A549/T cells was effectively overcome by PTX/TDNs.
- TDNs were found to downregulate the expression of mdr1 gene and P-gp, indicating their role as P-gp inhibitors.
- PTX/TDNs induced apoptosis in cancer cells.
Conclusions:
- PTX/TDNs exhibit potent anti-cancer activity and overcome paclitaxel resistance in NSCLC.
- TDNs function as P-gp inhibitors, contributing to the reversal of multidrug resistance.
- PTX/TDNs hold significant potential as an effective nanodelivery system for treating paclitaxel-resistant NSCLC.
Related Concept Videos
Crystal Field Theory - Tetrahedral and Square Planar Complexes
Crystal field theory (CFT) is applicable to molecules in geometries other than octahedral. In octahedral complexes, the lobes of the dx2−y2 and dz2 orbitals point directly at the ligands. For tetrahedral complexes, the d orbitals remain in place, but with only four ligands located between the axes. None of the orbitals points directly at the tetrahedral ligands. However, the dx2−y2 and dz2 orbitals (along the Cartesian axes) overlap with the ligands less than the dxy,...
Treatment Resistant Cancers
Lung Capacity
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Resistivity
Resistance

